MONTREAL, Oct. 22,
2024 /CNW/ - The Good Shroom Co Inc. (TSXV: MUSH), an
emerging cannabis company, announces the launch of DYP's, an
innovative THC-infused pouch product, in Alberta, Canada's second-largest cannabis
market. The Good Shroom Co operates a portfolio of brands in
Quebec, where it sells a wide
range of products. The introduction of DYP's is a key component of
the company's national expansion strategy.
DYP's are discreet, easy-to-use pouches designed to be placed
between the lip and gum, delivering 10mg of THC per pouch, the
maximum legal dose. This product is the first of its kind in
Canada, offering consumers a
smoke-free, affordable, and convenient way to consume THC. The
product is arriving in Alberta
this week, with distribution scheduled to begin next week.
The decision to launch DYP's is driven by three key factors:
- Discreet and Familiar: DYP's resemble popular nicotine
pouches like Zyn and Zonnic which are well established in
Canada, making them a familiar
option for consumers. The format is discreet and easy to use,
offering an alternative to more traditional cannabis consumption
methods.
- Competitive Pricing: At a retail price of approximately
$20 per unit (10 pouches per
unit), DYP's offer consumers an affordable way to consume THC,
with each 10mg dose priced around $2.
- First-to-Market Advantage: DYP's are the first THC-infused
pouches available in Canada,
positioning The Good Shroom Co at the forefront of this new
category in the cannabis market.
The pouches will initially be available in two flavors,
Wintergreen and Honeydew, with additional flavors planned for
Ontario in early 2025. As new
opportunities arise in other provinces, the company plans to expand
distribution nationwide.
"We are thrilled to bring DYP's to market in Alberta," said Eric
Ronsse, CEO of The Good Shroom Co Inc. "This product launch
represents an important milestone for our company and for the
Canadian cannabis market. DYP's offer consumers a convenient,
affordable, and familiar way to consume THC, and we believe the
strong feedback from our sales team demonstrates the potential of
this new category."
The Good Shroom Co's sales team has been actively engaging
retailers to create awareness around the product, and initial
feedback has been overwhelmingly positive.
Product Highlights:
- Discreet THC-infused pouches, placed between the lip and
gum
- 10mg of THC per pouch, the maximum legal dose
- Available in Wintergreen and Honeydew flavors
- Retail price: ~ $20 per unit (10
pouches per unit)
- Launching in Alberta with
plans for expansion into Ontario
in 2025
The Good Shroom Co Inc. operates primarily in Quebec, where it manages a portfolio of brands
that offer a range of cannabis products. DYP's are the company's
first major expansion outside Quebec, forming a key part of its national
growth strategy.
About The Good Shroom Co Inc.
The Good Shroom Co Inc. is a publicly traded company (TSX.V:
MUSH) specializing in cannabis and wellness products. The company
focuses on developing innovative cannabis products that meet
consumer needs across Canada.
Website: www.thegoodshroom.co
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Cautionary Note Regarding Forward-Looking
Information
This press release contains statements which constitute
"forward-looking statements" and "forward-looking information"
within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current
expectations of the Corporation with respect to future business
activities and sales, including the anticipated orders to be placed
by the SQDC. Forward-looking statements are often identified by the
words "may", "would", "could", "should", "will", "intend", "plan",
"anticipate", "believe", "estimate", "expect" or similar
expressions. Investors are cautioned that forward-looking
statements are not based on historical facts but instead reflect
the Corporation's expectations, estimates or projections concerning
future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the
statements are made. Although the Corporation believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed thereon, as unknown or
unpredictable factors could have material adverse effects on future
results, performance or achievements. Among the key factors that
could cause actual results to differ materially from those
projected are the following: market acceptance of the Company's
hash and other cannabis products, changes in the vendor's business
or strategy, changes in our supplier's operations and pricing,
expectations regarding competition and their pricing strategy;
maintaining in good standing all necessary regulatory licenses and
authorizations for its products; the benefits, safety, efficacy,
dosing and social acceptance of cannabis related products and no
material changes in the legal environment; changes in applicable
laws and regulations compliance with extensive government
regulation; operational risks related to supply chain disruptions
and shortages. Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results may vary materially from
those described herein as intended, planned, anticipated, believed,
estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended and
such changes could be material. The Company does not intend, and do
not assume any obligation, to update the forward-looking statements
except as otherwise required by applicable law. Trading in the
securities of the Company should be considered highly
speculative.
SOURCE Good Shroom Co Inc. (The)
